This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

K. Thomas Robbins, MD; William Davidson, MD; Lester J. Peters, MD; Helmuth Goepfert, MD

Arch Otolaryngol Head Neck Surg. 1988;114(4):421-426.

Abstract
• The treatment of choice for supraglottic carcinomas of intermediate size (stages T2 and T3) remains controversial. Between 1974 and 1983 in our institution, 139 patients with supraglottic carcinoma of intermediate size were judged retrospectively to have been technically amenable to conservation surgery. Primary disease control at three years was achieved in 100% of the patients treated by supraglottic laryngectomy, 91% (34 patients) of those treated by total laryngectomy, and 69% (81 patients) of those treated by radiotherapy. Of the latter group, 62% were salvaged by total laryngectomy yielding a net three-year local control of 85%. Determinate five-year survival rates were 89% for supraglottic laryngectomy, 78% for total laryngectomy, and 70% for radiotherapy. Significant problems with aspiration occurred in four patients (16%) who were treated by conservation surgery, and two patients (8%) required a permanent tracheostomy. The results of this study show that supraglottic laryngectomy with postoperative radiotherapy as indicated is a highly effective method for the local control of supraglottic carcinoma of intermediate size that is amenable to conservation surgery.

(Arch Otolaryngol Head Neck Surg 1988;114:421-426)

Author Affiliations
From the Department of Head and Neck Surgery (Drs Robbins, Davidson, and Goepfert) and the Division of Radiotherapy (Dr Peters), The University of Texas M. D. Anderson Hospital and Tumor Institute, Houston. Dr Robbins is now with the Division of Otolaryngology–Head and Neck Surgery, University of California–San Diego Medical Center.

Footnotes
Accepted for publication Nov 15, 1987.

Read before the American Society for Head and Neck Surgery, Denver, April 28, 1987.

Reprint requests to Division of Otolaryngology–Head and Neck Surgery, Box H891B, University of California–San Diego Medical Center, 225 Dickinson St, San Diego, CA 92103 (Dr Robbins).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Transoral Carbon Dioxide Laser Supraglottic Laryngectomy and Irradiation in Stage I, II, and III Squamous Cell Carcinoma of the Supraglottic Larynx: Report of Southwest Oncology Group Phase 2 Trial S9709
Agrawal et al.
Arch Otolaryngol Head Neck Surg 2007;133:1044-1050.
ABSTRACT | FULL TEXT  

American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
Pfister et al.
JCO 2006;24:3693-3704.
ABSTRACT | FULL TEXT  

Transoral Laser Surgery of Supraglottic Cancer: Follow-up of 141 Patients
Iro et al.
Arch Otolaryngol Head Neck Surg 1998;124:1245-1250.
ABSTRACT | FULL TEXT